About Gentech Laboratories Private Limited
Data last updated: 13 February 2026
Gentech Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It specialises in brokerage and trading services, a part of the broader financial services sector. Incorporated on 15 May 1981, the company has been in operation for over 45 years.
Registered with ROC Mumbai under CIN U85195MH1981PLC024412.
Capital: an authorised share capital of ₹1 Cr and a paid-up capital of ₹60.06 Lakh. Formerly known as Gentech Laboratories Ltd. It is led by directors including Viraj Chandrakant Gandhi and Roopa Rajesh Gandhi.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.43 Cr, a growth of 39% compared to the previous year.
As per MCA filings, the company has open charges of ₹2.12 Cr and satisfied charges of ₹21.76 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gentechlabs.in.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressOffice No. 1002 10Th Floor One Lodha Place, Senapati Bapat Marg Lower Parel, Mumbai, Maharashtra, India – 400013
-
IndustryFinancial Services, Brokerage & Trading Services, Real Estate Financing
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Gentech Laboratories Private Limited
Gentech Laboratories Private Limited has one previous CIN (Corporate Identification Number): U85195MH1981PLC024412. The current CIN is U85195MH1981PTC024412, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85195MH1981PTC024412 | Current |
| U85195MH1981PLC024412 | Previous |
Business Activity of Gentech Laboratories Private Limited
Gentech Laboratories Private Limited is engaged in the principal business activity of trade, with detailed activities including retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | ********* |
Board of Directors of Gentech Laboratories Private Limited
Gentech Laboratories Private Limited is currently managed by 6 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Viraj Chandrakant Gandhi
Also directs:
Gentech Properties Private Limited, Novamox Vincom Pvt Ltd
|
Director | 27 Feb 2012 | 14 Years 4 Months | Current |
|
Roopa Rajesh Gandhi
Also directs:
Novamox Vincom Pvt Ltd, Antibiotic Stores Private Limited, Fusion Fiscal Services Private Ltd and 1 more
|
Additional Director | 07 May 2025 | 1 Years 2 Months | Current |
| Shibani Viraj Gandhi | Additional Director | 07 May 2025 | 1 Years 2 Months | Current |
|
Manharlal Jagjivandas Shah
Also directs:
Gentech Properties Private Limited
|
Whole-Time Director | 27 Apr 1995 | 31 Years 2 Months | Current |
|
Dhanlaxmi Chandrakant Gandhi
Also directs:
Novamox Vincom Pvt Ltd
|
Additional Director | 01 May 2025 | 1 Years 2 Months | Current |
|
Rajesh Chandrakant Gandhi
Also directs:
Novamox Vincom Pvt Ltd, Antibiotic Stores Private Limited, Fusion Fiscal Services Private Ltd and 2 more
|
Whole-Time Director | 12 Nov 2009 | 16 Years 7 Months | Current |
Financials of Gentech Laboratories Private Limited FY 2025 filings available
Gentech Laboratories Private Limited reported revenue of ₹8.43 Cr (up 39% YoY) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Gentech Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Sep 2024 | Others | ₹1.18 Cr | Open |
| 20 Jun 2002 | Kapole Co-Op Bank Ltd | ₹4.75 Lakh | Open |
| 17 Jun 1988 | Indian Bank | ₹51 Lakh | Open |
| 20 Aug 1987 | Indian Bank | ₹9.5 Lakh | Open |
| 11 Aug 1986 | Indian Bank | ₹4.5 Lakh | Open |
Total charge records: 10 View all charges
Employees and EPFO Compliance at Gentech Laboratories Private Limited
View historical data on people associated with Gentech Laboratories Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Gentech Laboratories Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Gentech Laboratories Private Limited
GSTIN & GST Filing Data of Gentech Laboratories Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Gentech Laboratories Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Gentech Laboratories Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Gentech Laboratories Private Limited
MSME Payment Delays by Gentech Laboratories Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Gentech Laboratories Private Limited
Subsidiaries & Group Companies of Gentech Laboratories Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Gentech Laboratories Private Limited with ownership details.
MCA Filings & Documents of Gentech Laboratories Private Limited
MCA Filings & Documents of Gentech Laboratories Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Gentech Laboratories Private Limited
Frequently Asked Questions about Gentech Laboratories Private Limited
Gentech Laboratories Private Limited is an active private limited company in the financial services sector based in Mumbai, Maharashtra, India. It was incorporated on 15 May 1981 (45+ years old) and is registered under CIN U85195MH1981PTC024412.
Gentech Laboratories Private Limited reported revenue of ₹8.43 Cr for FY 2024 (up 39.00% YoY).
The current directors of Gentech Laboratories Private Limited are:
The primary industry of Gentech Laboratories Private Limited is financial services. The company specifically operates in brokerage and trading services. The company is currently active in this sector.
Gentech Laboratories Private Limited can be reached at the registered office: Office No. 1002 10Th Floor One Lodha Place, Senapati Bapat Marg Lower Parel, Mumbai, Maharashtra, India – 400013, or through the website gentechlabs.in.
The authorised capital is ₹1 Cr, and the paid-up capital is ₹60.06 Lakh.